S
Sam Chun Dang Pharm Co Ltd
KOSDAQ:000250
Sam Chun Dang Pharm Co Ltd
KOSDAQ:000250
Price:
104 000
KRW
-0.76%
Market Closed
Market Cap:
2.4T
KRW
Add
Note
Why Create Notes?
Capture your thoughts
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Peter Lynch
Track and Analyze Performance
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Continuous Learning and Adaptation
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
Boost Decision Confidence
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Delete Note
Do you really want to delete this note?
This action cannot be undone.
Alert
Sam Chun Dang Pharm Co Ltd
104000
-800 (-0.76%)
| 52 Week Range |
62 400
214 000
|
| Price Target |
|
We'll email you a reminder when the closing price reaches KRW.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Walmart Inc
NYSE:WMT
|
US |
|
|
Verizon Communications Inc
NYSE:VZ
|
US |
Delete Alert
This alert will be permanently deleted.
Ask me anything about
Sam Chun Dang Pharm Co Ltd
Income Statement
Earnings Waterfall
Sam Chun Dang Pharm Co Ltd
Sam Chun Dang Pharm Co Ltd
|
Revenue
|
208.2B
KRW
|
|
Cost of Revenue
|
-109.5B
KRW
|
|
Gross Profit
|
98.7B
KRW
|
|
Operating Expenses
|
-94.5B
KRW
|
|
Operating Income
|
4.2B
KRW
|
|
Other Expenses
|
884m
KRW
|
|
Net Income
|
5.1B
KRW
|
Income Statement
Sam Chun Dang Pharm Co Ltd
Sam Chun Dang Pharm Co Ltd
Currency: KRW
| Sep-2014 | Dec-2014 | Mar-2015 | Jun-2015 | Sep-2015 | Dec-2015 | Mar-2016 | Jun-2016 | Sep-2016 | Dec-2016 | Mar-2017 | Jun-2017 | Sep-2017 | Dec-2017 | Mar-2018 | Jun-2018 | Sep-2018 | Dec-2018 | Mar-2019 | Jun-2019 | Sep-2019 | Dec-2019 | Mar-2020 | Jun-2020 | Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | ||||||||||||||||||||||||||||||||||||||||||
| Revenue |
113 868
N/A
|
118 924
+4%
|
121 560
+2%
|
124 624
+3%
|
129 274
+4%
|
132 062
+2%
|
135 871
+3%
|
140 601
+3%
|
143 254
+2%
|
147 373
+3%
|
152 190
+3%
|
154 663
+2%
|
161 678
+5%
|
160 587
-1%
|
161 472
+1%
|
163 480
+1%
|
159 846
-2%
|
159 960
+0%
|
163 522
+2%
|
167 880
+3%
|
180 333
+7%
|
186 602
+3%
|
184 646
-1%
|
183 207
-1%
|
171 989
-6%
|
166 862
-3%
|
164 876
-1%
|
162 000
-2%
|
163 026
+1%
|
167 275
+3%
|
169 530
+1%
|
175 261
+3%
|
176 520
+1%
|
177 335
+0%
|
179 673
+1%
|
180 070
+0%
|
184 682
+3%
|
192 669
+4%
|
196 971
+2%
|
204 281
+4%
|
208 221
+2%
|
|
| Gross Profit | ||||||||||||||||||||||||||||||||||||||||||
| Cost of Revenue |
(50 539)
|
(53 659)
|
(55 949)
|
(57 728)
|
(59 760)
|
(60 052)
|
(61 714)
|
(63 906)
|
(65 460)
|
(68 299)
|
(70 440)
|
(72 287)
|
(76 163)
|
(75 822)
|
(77 456)
|
(77 320)
|
(74 991)
|
(76 762)
|
(76 256)
|
(75 730)
|
(75 813)
|
(75 947)
|
(74 821)
|
(75 032)
|
(73 650)
|
(72 862)
|
(75 090)
|
(76 677)
|
(78 966)
|
(84 197)
|
(84 471)
|
(88 331)
|
(89 503)
|
(87 341)
|
(88 641)
|
(87 587)
|
(90 814)
|
(95 702)
|
(98 791)
|
(104 991)
|
(109 518)
|
|
| Gross Profit |
63 329
N/A
|
65 265
+3%
|
65 611
+1%
|
66 895
+2%
|
69 514
+4%
|
72 010
+4%
|
74 156
+3%
|
76 694
+3%
|
77 793
+1%
|
79 074
+2%
|
81 750
+3%
|
82 376
+1%
|
85 514
+4%
|
84 765
-1%
|
84 016
-1%
|
86 160
+3%
|
84 856
-2%
|
83 198
-2%
|
87 266
+5%
|
92 151
+6%
|
104 521
+13%
|
110 656
+6%
|
109 826
-1%
|
108 174
-2%
|
98 338
-9%
|
94 000
-4%
|
89 785
-4%
|
85 323
-5%
|
84 060
-1%
|
83 078
-1%
|
85 058
+2%
|
86 931
+2%
|
87 017
+0%
|
89 995
+3%
|
91 032
+1%
|
92 483
+2%
|
93 867
+1%
|
96 966
+3%
|
98 179
+1%
|
99 290
+1%
|
98 703
-1%
|
|
| Operating Income | ||||||||||||||||||||||||||||||||||||||||||
| Operating Expenses |
(44 844)
|
(46 322)
|
(47 062)
|
(48 186)
|
(49 883)
|
(51 248)
|
(52 566)
|
(53 612)
|
(54 128)
|
(54 716)
|
(56 002)
|
(58 018)
|
(59 751)
|
(60 796)
|
(61 437)
|
(61 280)
|
(61 370)
|
(67 699)
|
(70 640)
|
(74 128)
|
(82 332)
|
(85 446)
|
(87 628)
|
(90 739)
|
(92 025)
|
(88 477)
|
(93 035)
|
(93 614)
|
(100 942)
|
(98 371)
|
(92 704)
|
(89 866)
|
(77 301)
|
(77 770)
|
(80 558)
|
(81 774)
|
(84 521)
|
(87 406)
|
(89 649)
|
(91 865)
|
(94 477)
|
|
| Selling, General & Administrative |
(42 769)
|
(43 859)
|
(44 407)
|
(44 868)
|
(45 752)
|
(46 895)
|
(48 081)
|
(49 356)
|
(50 384)
|
(51 302)
|
(52 550)
|
(53 570)
|
(54 998)
|
(55 675)
|
(56 252)
|
(56 893)
|
(56 922)
|
(58 180)
|
(59 977)
|
(62 092)
|
(64 119)
|
(66 326)
|
(67 232)
|
(67 097)
|
(67 617)
|
(65 829)
|
(65 216)
|
(64 617)
|
(63 873)
|
(64 151)
|
(64 452)
|
(66 228)
|
(67 916)
|
(70 213)
|
(72 912)
|
(74 821)
|
(77 230)
|
(79 885)
|
(80 660)
|
(82 342)
|
(83 715)
|
|
| Research & Development |
(1 679)
|
(2 066)
|
(2 288)
|
(2 980)
|
(3 822)
|
(4 069)
|
(4 157)
|
(3 886)
|
(3 332)
|
(2 950)
|
(2 991)
|
(3 982)
|
(4 269)
|
(4 622)
|
(4 656)
|
(3 838)
|
(3 891)
|
(8 959)
|
(10 005)
|
(11 260)
|
(17 296)
|
(17 924)
|
(18 994)
|
(22 219)
|
(22 249)
|
(21 181)
|
(25 596)
|
(27 328)
|
(35 631)
|
(32 389)
|
(26 271)
|
(21 351)
|
(6 952)
|
(5 471)
|
(5 390)
|
(4 537)
|
(4 849)
|
(5 042)
|
(5 406)
|
(5 904)
|
(7 087)
|
|
| Depreciation & Amortization |
(395)
|
(397)
|
(367)
|
(338)
|
(310)
|
(283)
|
(327)
|
(369)
|
(412)
|
(464)
|
(461)
|
(465)
|
(482)
|
(499)
|
(528)
|
(549)
|
(557)
|
(559)
|
(658)
|
(776)
|
(917)
|
(1 195)
|
(1 293)
|
(1 422)
|
(1 507)
|
(1 467)
|
(1 572)
|
(1 670)
|
(1 757)
|
(1 831)
|
(1 811)
|
(1 798)
|
(1 944)
|
(2 086)
|
(2 256)
|
(2 415)
|
(2 441)
|
(2 480)
|
(2 538)
|
(2 574)
|
(2 631)
|
|
| Other Operating Expenses |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(109)
|
0
|
(652)
|
0
|
(651)
|
0
|
318
|
0
|
(171)
|
(489)
|
(489)
|
0
|
0
|
0
|
0
|
0
|
(1 045)
|
(1 045)
|
(1 045)
|
|
| Operating Income |
18 484
N/A
|
18 943
+2%
|
18 550
-2%
|
18 710
+1%
|
19 631
+5%
|
20 763
+6%
|
21 590
+4%
|
23 082
+7%
|
23 665
+3%
|
24 358
+3%
|
25 748
+6%
|
24 359
-5%
|
25 765
+6%
|
23 969
-7%
|
22 579
-6%
|
24 880
+10%
|
23 485
-6%
|
15 500
-34%
|
16 626
+7%
|
18 022
+8%
|
22 188
+23%
|
25 210
+14%
|
22 198
-12%
|
17 436
-21%
|
6 314
-64%
|
5 523
-13%
|
(3 250)
N/A
|
(8 291)
-155%
|
(16 882)
-104%
|
(15 293)
+9%
|
(7 646)
+50%
|
(2 936)
+62%
|
9 716
N/A
|
12 225
+26%
|
10 474
-14%
|
10 709
+2%
|
9 347
-13%
|
9 560
+2%
|
8 530
-11%
|
7 425
-13%
|
4 226
-43%
|
|
| Pre-Tax Income | ||||||||||||||||||||||||||||||||||||||||||
| Interest Income Expense |
1 327
|
1 821
|
1 558
|
1 592
|
1 462
|
1 243
|
1 204
|
1 160
|
975
|
1 097
|
785
|
786
|
964
|
1 183
|
1 421
|
1 478
|
1 602
|
1 465
|
1 515
|
(929)
|
(1 514)
|
(4 045)
|
(3 900)
|
215
|
(4 515)
|
14 752
|
14 291
|
12 480
|
17 789
|
(4 019)
|
(4 260)
|
(6 139)
|
(6 979)
|
(4 862)
|
(4 788)
|
(8 151)
|
(19 604)
|
(13 445)
|
(12 268)
|
(4 894)
|
7 792
|
|
| Non-Reccuring Items |
42
|
(4)
|
(21)
|
(110)
|
(77)
|
(1 099)
|
(1 090)
|
(1 016)
|
(1 183)
|
155
|
12
|
(15)
|
134
|
(960)
|
(812)
|
(858)
|
(1 599)
|
(2 241)
|
(1 638)
|
(1 466)
|
(593)
|
(138)
|
0
|
(677)
|
0
|
0
|
0
|
318
|
0
|
(489)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(1 045)
|
0
|
0
|
0
|
|
| Gain/Loss on Disposition of Assets |
0
|
(779)
|
(789)
|
(792)
|
(792)
|
(16)
|
(7)
|
(5)
|
(4)
|
(1 252)
|
(1 254)
|
(1 252)
|
(1 253)
|
(2)
|
(235)
|
(500)
|
(492)
|
(15)
|
(801)
|
(832)
|
(1 061)
|
(1 486)
|
(1 212)
|
0
|
(1 103)
|
(519)
|
109
|
126
|
535
|
42
|
16
|
2
|
758
|
799
|
1 096
|
0
|
335
|
296
|
(100)
|
(109)
|
(106)
|
|
| Total Other Income |
(5 741)
|
26
|
(87)
|
(211)
|
(146)
|
(52)
|
(90)
|
(116)
|
(150)
|
(1 702)
|
(1 584)
|
(1 644)
|
(1 645)
|
(112)
|
(115)
|
(200)
|
(303)
|
(247)
|
(250)
|
(227)
|
(87)
|
(223)
|
(177)
|
(1 125)
|
(867)
|
(3 176)
|
(3 107)
|
(2 976)
|
(2 276)
|
210
|
144
|
598
|
834
|
759
|
711
|
1 384
|
(6)
|
86
|
100
|
(16)
|
(21)
|
|
| Pre-Tax Income |
14 112
N/A
|
20 008
+42%
|
19 211
-4%
|
19 190
0%
|
20 079
+5%
|
20 838
+4%
|
21 608
+4%
|
23 105
+7%
|
23 303
+1%
|
22 656
-3%
|
23 706
+5%
|
22 234
-6%
|
23 964
+8%
|
24 078
+0%
|
22 838
-5%
|
24 799
+9%
|
22 693
-8%
|
14 461
-36%
|
15 452
+7%
|
14 568
-6%
|
18 933
+30%
|
19 317
+2%
|
16 909
-12%
|
15 849
-6%
|
(172)
N/A
|
16 581
N/A
|
8 042
-51%
|
1 655
-79%
|
(834)
N/A
|
(19 549)
-2 244%
|
(11 746)
+40%
|
(8 474)
+28%
|
4 329
N/A
|
8 920
+106%
|
7 493
-16%
|
3 942
-47%
|
(9 927)
N/A
|
(4 549)
+54%
|
(3 738)
+18%
|
2 405
N/A
|
11 891
+394%
|
|
| Net Income | ||||||||||||||||||||||||||||||||||||||||||
| Tax Provision |
(2 427)
|
(2 744)
|
(2 782)
|
(2 695)
|
(2 725)
|
(2 964)
|
(3 060)
|
(3 278)
|
(3 345)
|
(7 042)
|
(6 989)
|
(6 956)
|
(7 236)
|
(3 593)
|
(3 856)
|
(4 398)
|
(3 049)
|
132
|
305
|
704
|
(92)
|
282
|
974
|
1 293
|
(179)
|
(9 086)
|
(7 533)
|
(6 891)
|
1 398
|
9 188
|
7 624
|
7 268
|
485
|
(88)
|
(518)
|
(443)
|
(837)
|
361
|
681
|
(1 682)
|
(1 113)
|
|
| Income from Continuing Operations |
11 685
|
17 264
|
16 429
|
16 495
|
17 355
|
17 875
|
18 549
|
19 828
|
19 958
|
15 614
|
16 717
|
15 277
|
16 727
|
20 485
|
18 980
|
20 400
|
19 643
|
14 593
|
15 758
|
15 273
|
18 843
|
19 600
|
17 883
|
17 142
|
(353)
|
7 495
|
509
|
(5 235)
|
565
|
(10 361)
|
(4 122)
|
(1 206)
|
4 814
|
8 832
|
6 975
|
3 498
|
(10 764)
|
(4 188)
|
(3 057)
|
724
|
10 779
|
|
| Income to Minority Interest |
(1 808)
|
(5 416)
|
(5 668)
|
(6 104)
|
(6 398)
|
(6 246)
|
(6 368)
|
(6 599)
|
(6 602)
|
(6 902)
|
(7 650)
|
(7 865)
|
(8 713)
|
(7 970)
|
(7 582)
|
(7 408)
|
(6 571)
|
(5 838)
|
(6 389)
|
(6 907)
|
(7 338)
|
(9 148)
|
(9 295)
|
(9 265)
|
(8 334)
|
(8 461)
|
(6 953)
|
(5 617)
|
(6 236)
|
(6 194)
|
(6 351)
|
(5 701)
|
(4 999)
|
(2 994)
|
(2 607)
|
(4 071)
|
(4 273)
|
(6 195)
|
(6 542)
|
(6 315)
|
(5 669)
|
|
| Net Income (Common) |
9 874
N/A
|
11 848
+20%
|
10 759
-9%
|
10 390
-3%
|
10 957
+5%
|
11 628
+6%
|
12 180
+5%
|
13 228
+9%
|
13 355
+1%
|
8 712
-35%
|
9 067
+4%
|
7 412
-18%
|
8 014
+8%
|
12 515
+56%
|
11 398
-9%
|
12 992
+14%
|
13 071
+1%
|
8 754
-33%
|
9 367
+7%
|
8 363
-11%
|
11 502
+38%
|
10 452
-9%
|
8 586
-18%
|
7 876
-8%
|
(8 686)
N/A
|
(966)
+89%
|
(6 443)
-567%
|
(10 852)
-68%
|
(5 671)
+48%
|
(16 555)
-192%
|
(10 473)
+37%
|
(6 908)
+34%
|
(185)
+97%
|
5 838
N/A
|
4 368
-25%
|
(573)
N/A
|
(15 038)
-2 524%
|
(10 383)
+31%
|
(9 599)
+8%
|
(5 592)
+42%
|
5 110
N/A
|
|
| EPS (Diluted) |
470.19
N/A
|
564.19
+20%
|
537.95
-5%
|
494.76
-8%
|
521.76
+5%
|
553.71
+6%
|
580
+5%
|
629.9
+9%
|
635.95
+1%
|
414.85
-35%
|
431.76
+4%
|
336.9
-22%
|
381.61
+13%
|
595.95
+56%
|
542.76
-9%
|
618.66
+14%
|
622.42
+1%
|
416.85
-33%
|
425.77
+2%
|
398.23
-6%
|
547.71
+38%
|
497.71
-9%
|
408.85
-18%
|
375.04
-8%
|
-394.81
N/A
|
-43.9
+89%
|
-292.86
-567%
|
-491.73
-68%
|
-256.99
+48%
|
-750.19
-192%
|
-461.01
+39%
|
-303.53
+34%
|
-8.14
+97%
|
264.52
N/A
|
197.72
-25%
|
-25.97
N/A
|
-681.45
-2 524%
|
-463.03
+32%
|
-421.8
+9%
|
-245.46
+42%
|
219.72
N/A
|
|
Switch to:
Switch to:
See Also
Discover More
You don't have any saved screeners yet
